Tetrabarbital
A barbiturate derivative used in medicine
| Tetrabarbital | |
|---|---|
|
| |
| Chemical nomenclature | |
| IUPAC name | 5-ethyl-5-(4-methylpent-3-en-1-yl)-1,3-diazinane-2,4,6-trione
|
Tetrabarbital is a barbiturate derivative that has been used in medicine primarily for its sedative and hypnotic properties. It is a central nervous system depressant that works by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor.
Pharmacology[edit]
Tetrabarbital acts as a positive allosteric modulator of the GABA_A receptor, which increases the inhibitory effects of GABA in the central nervous system. This results in a calming effect, making it useful for inducing sleep and reducing anxiety.
Medical uses[edit]
Tetrabarbital has been used in the past for the treatment of insomnia, anxiety disorders, and as a pre-anesthetic agent. However, due to the development of safer and more effective medications, its use has declined significantly.
Side effects[edit]
Common side effects of tetrabarbital include drowsiness, dizziness, and headache. More serious side effects can include respiratory depression, hypotension, and allergic reactions.
History[edit]
Barbiturates, including tetrabarbital, were first synthesized in the early 20th century and became widely used for their sedative and hypnotic effects. Over time, the development of benzodiazepines and other anxiolytics led to a decline in the use of barbiturates due to their potential for addiction and overdose.
Chemical structure[edit]

Tetrabarbital is a derivative of barbituric acid, with a chemical structure that includes a pyrimidine ring. The presence of an ethyl group and a 4-methylpent-3-en-1-yl group at the 5-position of the ring distinguishes it from other barbiturates.
Synthesis[edit]
The synthesis of tetrabarbital involves the reaction of barbituric acid with appropriate alkylating agents to introduce the ethyl and 4-methylpent-3-en-1-yl groups.
Regulation[edit]
Due to its potential for abuse and dependence, tetrabarbital is classified as a controlled substance in many countries. Its use is restricted to specific medical indications and is subject to regulatory oversight.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian